Cargando…

Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases

BACKGROUND: Hepatic steatosis commonly occurs in some chronic liver diseases and may affect disease progression. AIM: To investigate the performance of controlled attenuation parameter (CAP) for the diagnosis of hepatic steatosis in patients with autoimmune liver diseases (AILDs). METHODS: Patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Xi-Xi, Lian, Min, Wu, Hui-Min, Li, Xiao-Yun, Sheng, Li, Bao, Han, Miao, Qi, Xiao, Xiao, Guo, Can-Jie, Li, Hai, Ma, Xiong, Hua, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789069/ https://www.ncbi.nlm.nih.gov/pubmed/33505152 http://dx.doi.org/10.3748/wjg.v27.i1.80

Ejemplares similares

Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome
por: Wu, Hui-Min, et al.
Publicado: (2018)

Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
por: Steinmann, Silja, et al.
Publicado: (2023)

Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
por: Shin, Hyun Joo, et al.
Publicado: (2018)

Autoimmune liver disease-related autoantibodies in patients with biliary atresia
por: Pang, Shu-Yin, et al.
Publicado: (2018)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

A Model Construction of Starvation Induces Hepatic Steatosis and Transcriptome Analysis in Zebrafish Larvae
por: Xu, Hao, et al.
Publicado: (2021)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2019)

Relationship between phase angle, steatosis, and liver fibrosis in patients coinfected with human immunodeficiency virus/hepatitis C virus
por: Fernandes, Sabrina Alves, et al.
Publicado: (2022)

Clinical characteristics and 28-d outcomes of bacterial infections in patients with hepatitis B virus-related acute-on-chronic liver failure
por: Li, Chen, et al.
Publicado: (2020)

S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis
por: Tsuji, Kunihiro, et al.
Publicado: (2017)

Relationship between serum adenosine deaminase levels and liver histology in autoimmune hepatitis
por: Torgutalp, Murat, et al.
Publicado: (2017)

Intra-arterial thrombolysis for early hepatic artery thrombosis after liver transplantation
por: Li, Ting, et al.
Publicado: (2021)

Neoadjuvant transcatheter arterial chemoembolization and systemic chemotherapy for the treatment of undifferentiated embryonal sarcoma of the liver in children
por: He, Min, et al.
Publicado: (2022)

Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
por: Ayoub, Fares, et al.
Publicado: (2018)

Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis
por: Guo, Jian-Hai, et al.
Publicado: (2017)

Effects of different intervention methods on psychological flexibility, negative emotions and sleep quality in chronic hepatitis B
por: Zheng, Ying, et al.
Publicado: (2023)

Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis
por: LIAN, FAN, et al.
Publicado: (2015)

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
por: Ahn, Jem Ma, et al.
Publicado: (2016)

Undifferentiated embryonal sarcoma of the liver: Clinical characteristics and outcomes
por: Zhang, Chong, et al.
Publicado: (2020)

Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis
por: Zhao, Yanan, et al.
Publicado: (2022)

Clinical value of predictive models based on liver stiffness measurement in predicting liver reserve function of compensated chronic liver disease
por: Lai, Rui-Min, et al.
Publicado: (2022)

Endoscopic ultrasound features of autoimmune pancreatitis: The typical findings and chronic pancreatitis changes
por: Zhang, Sheng-Yu, et al.
Publicado: (2021)

Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
por: Apostolov, Ross, et al.
Publicado: (2022)

High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure
por: Zhou, Chao, et al.
Publicado: (2020)

Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Qu, Ying, et al.
Publicado: (2021)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
por: Kim, Pyeong Hwa, et al.
Publicado: (2022)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
por: Ogino, Yu, et al.
Publicado: (2021)

Differentiation of atypical hepatic hemangioma from liver metastases: Diagnostic performance of a novel type of color contrast enhanced ultrasound
por: Wu, Xiao-Feng, et al.
Publicado: (2020)

Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis
por: Elfaal, Mohamed, et al.
Publicado: (2023)

IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
por: Gao, Yinjie, et al.
Publicado: (2016)

How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
por: Seo, Duck Min, et al.
Publicado: (2023)

MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells
por: Chen, Yong, et al.
Publicado: (2021)

A new visual quantitative assessment of ultrasound attenuation parameters for the mild liver steatosis
por: Ren, Xinping, et al.
Publicado: (2022)

Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet
por: Dai, Yun-Kai, et al.
Publicado: (2023)

Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
por: Jung, Kyu Sik, et al.
Publicado: (2014)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
por: Kang, Na-Ling, et al.
Publicado: (2020)

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver
por: Zhang, Yuehui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7macf9dumf2fvq6pj4dht8uv41